Tetrahydrocannabiphorol Facts
Cannabinoid;
Description
THCP (tetrahydrocannabiphorol) is a cannabinoid of the dibenzopyran class. It resembles Δ9-THC but carries a longer carbon chain that dramatically increases its potency. It activates cannabinoid receptors roughly 33 times more strongly than THC,[1] producing intense sedation and a powerful cannabis-like high.
Subjective effects include heavy sedation, intense euphoria, appetite stimulation, altered time perception, and marked short-term memory loss. The experience resembles cannabis but amplified — heavier, more disorienting, and capable of overwhelming cognitive function at doses where THC would cause only mild intoxication.[2]
THCP carries elevated dependence and acute toxicity risk relative to THC. It drives cannabinoid receptors to their maximum — unlike THC, which has a built-in ceiling — predicting faster tolerance and a lower threshold for severe reactions including seizure.[3][4]
Dose and durationby route · individual sensitivity varies
Starts in 30 – 90 minLasts 4 – 10 hoursAfter-effects 4 – 24 hours
Body and dependence
- Acute toxicity
- Moderate
- Chronic toxicity
- Moderate
- Physical dependence
- Moderate
- Psychological dependence
- Moderate
- Withdrawal
- Moderate
- Compulsive redosing
- Moderate
Tolerance
- Builds
- Moderate
- Fully resets after
- 3 weeks
- Carries over to
- Δ9-THC;
Δ8-THC; HHC; HHCP; synthetic cannabinoids
Effectslikely at a common dose
- Perception
- none likely · 22 possible, including Spatial disorientation, Visual acuity suppression, Visual haze / noise
- Body
- Body high;
Dry mouth; Motor control impairment; Sedation; +24 possible, including Heart rate perception changes, Abnormal heartbeat, Dehydration sensation - Thinking
- Cognitive impairment;
+31 possible, including Decision impairment, Memory suppression, Analysis suppression - Feeling
- none likely · 11 possible, including Anxiety, Paranoia, Emotional lability
- Self
- none likely · 14 possible, including Communication suppression, Craving, Depersonalization
- Time
- Time alteration;
+3 possible, including Temporal disorientation - Awareness
- none likely · 3 possible
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
Natural cannabis rarely causes a medical emergency — "greening out" is: pale/sweaty skin, dizziness, nausea or vomiting, anxiety or panic, rapid heartbeat, feeling faint — and usually passes with rest.
Seek emergency help for these — far more likely with synthetic cannabinoids ("spice" / K2):
- Seizures
- Severe chest pain; very fast or irregular heartbeat
- Unresponsiveness or extreme drowsiness
- Severe agitation, aggression, or psychosis
- Repeated vomiting; difficulty breathing
What to do
- Sit or lie them down somewhere calm, cool, and quiet
- Reassure them — cannabis panic and "greening out" pass with time
- Offer sips of water; a little sugar can help if they feel faint
- Recovery position if nauseated, drowsy, or vomiting
- Stay with them and monitor
- For seizures, chest pain, unresponsiveness, or severe agitation, call emergency services
Natural cannabis "greening out" resolves with rest, calm, and time, with no lasting harm. Synthetic cannabinoids are unpredictable and can cause seizures, cardiac events, kidney injury, and severe agitation that needs emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Citti C, Linciano P, Russo F, Luongo L, Iannotta M, Maione S, Laganà A, Capriotti AL, Forni F, Vandelli MA, Gigli G, Cannazza G (2019) A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol — Scientific Reports doi:10.1038/s41598-019-56785-1
- [2]^Caprari C, Ferri E, Vandelli MA, Citti C, Cannazza G (2024) An emerging trend in Novel Psychoactive Substances (NPSs): designer THC — Journal of Cannabis Research doi:10.1186/s42238-024-00226-y
- [3]^Fattore L, Fratta W (2011) Beyond THC: The New Generation of Cannabinoid Designer Drugs — Frontiers in Behavioral Neuroscience doi:10.3389/fnbeh.2011.00060
- [4]^Janssens LK, Van Uytfanghe K, Williams JB, Hering KW, Iula DM, Stove CP (2024) Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays - and how this matters for the harm potential of seized drugs — Archives of Toxicology doi:10.1007/s00204-024-03769-4